Literature DB >> 25664700

Variations in time of market exclusivity among top-selling prescription drugs in the United States.

Bo Wang1, Jun Liu1, Aaron S Kesselheim1.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 25664700     DOI： 10.1001/jamainternmed.2014.7968

Source DB:  PubMed          Journal:  JAMA Intern Med        ISSN： 2168-6106            Impact factor:   21.873


× No keyword cloud information.
  5 in total

Review 1.  Sustainable Financing of Innovative Therapies: A Review of Approaches.

Authors:  Aidan Hollis
Journal:  Pharmacoeconomics       Date:  2016-10       Impact factor: 4.981

2.  Research and Development Spending to Bring a Single Cancer Drug to Market and Revenues After Approval.

Authors:  Vinay Prasad; Sham Mailankody
Journal:  JAMA Intern Med       Date:  2017-11-01       Impact factor: 21.873

Review 3.  The high price of anticancer drugs: origins, implications, barriers, solutions.

Authors:  Vinay Prasad; Kevin De Jesús; Sham Mailankody
Journal:  Nat Rev Clin Oncol       Date:  2017-03-14       Impact factor: 66.675

4.  Approvals and Timing of New Formulations of Novel Drugs Approved by the US Food and Drug Administration Between 1995 and 2010 and Followed Through 2021.

Authors:  Ravi Gupta; Christopher J Morten; Angela Y Zhu; Reshma Ramachandran; Nilay D Shah; Joseph S Ross
Journal:  JAMA Health Forum       Date:  2022-05-20

5.  The timing of 30-month stay expirations and generic entry: A cohort study of first generics, 2013-2020.

Authors:  Sunand Kannappan; Jonathan J Darrow; Aaron S Kesselheim; Reed F Beall
Journal:  Clin Transl Sci       Date:  2021-05-31       Impact factor: 4.689
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.